Refine by MP, party, committee, province, or result type.

Results 1-5 of 5

Health committee  In Ontario, there is a Citizens' Council. The Citizens' Council has explored the issue of rare diseases and has made recommendations on how we should make funding decisions concerning treatments for rare diseases. I suggest you look at that approach that is taken there. They have

April 16th, 2013Committee meeting

Dr. Doug Coyle

Health committee  It's a good question. I didn't mention this earlier because I wasn't sure it would be coming up in the discussion today; I'm a member of the drugs for rare disease working group in Ontario. We have developed a completely new framework for making decisions about technologies fo

April 16th, 2013Committee meeting

Dr. Doug Coyle

Health committee  Thank you. I will try to answer the first question. I'm not sure I can provide much input for the second. There is research that's been done on trying to reorganize primary care to try to make it more efficient, and doing some of the services you've mentioned, which is the dela

April 16th, 2013Committee meeting

Dr. Doug Coyle

Health committee  I think the idea that CIHR should focus on the evaluation of the organization of health care, not just the evaluation of the value of new technologies, would be a good step forward.

April 16th, 2013Committee meeting

Dr. Doug Coyle

Health committee  I tend to try to hide in the shadows, so it's okay. My name is Doug Coyle. Thank you very much for giving me the opportunity to present my views today. I am a health economist and have worked in this research area for the past 24 years. I am based at the University of Ottawa, w

April 16th, 2013Committee meeting

Dr. Doug Coyle